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Abstract. Study Objective: Adolescent compliance with
cytologic and histologic cervical abnormalities is poor.
Recent changes in abnormal cytology follow-up and colposcopy indications in young women may delay the diagnosis
of cervical dysplasia. The objective of our study was to
determine the compliance with follow up. We also wanted
to summarize regression or progression of disease, and to
determine if the new guidelines could affect severity and time
of diagnosis.
Design: Retrospective review of medical records from
adolescent patients (defined as women aged 12 to 21)
who had a colposcopy between January 2004 and December 2006. Patients were excluded if they were 22 or older
or if they had a previously abnormal cytologic evaluation.
Main Outcome Measures: Colposcopy records between
January 2004 and December 2006 were identified by CPT
code from a computerized database. Cytology and histology
results, follow-up compliance rates, and demographic data
were collected. Data were analyzed with a power O 85%
and a P value # .05 for significance.
Results: Of the 210 records reviewed, 61.9% had atypical squamous cells of undetermined significance high-risk
HPV, 33.7% had low-grade squamous intraepithelial lesion,
and 4.5% had high-grade squamous intraepithelial lesions.
Colposcopy was performed in 55.9%, and 15.2% required
surgical intervention. Loop electrosurgical excision procedure (LEEP) was used in 87.5% of patients, and 12.5%
had a cold knife cone. Mean time to follow in patients with
a surgical intervention was 12.72 months and 11.02 months
for those without (P 5 .371).
Conclusion: There appears to be no difference in compliance with follow-up, regardless of severity of disease
or surgical intervention. There was no significant progression of disease and a high regression rate of abnormalities.

This information supports the current American College
of Obstetricians and Gynecologists and American Society
for Colposcopy and Cervical Pathology guidelines to delay
aggressive intervention in adolescents.
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Cervical dysplasia is a premalignant change in the cervical epithelium that may progress to cervical cancer.
Human papillomavirus (HPV) is the greatest risk factor
for cervical dysplasia and is the most common sexually
transmitted infection in the United States.1 Risk factors
for cervical dysplasia, which have been identified,
include smoking, young age of first intercourse, large
number of sexual partners, infrequent use of barrier
methods, and susceptibility of the adolescent cervix
to the acquisition of the HPV virus.2 The consensus
conference sponsored by the American Society of
Colposcopy and Cervical Pathology (ASCCP) in
2006 established management guidelines, which differ
from previous years, for adolescent women with cervical cytologic and histologic abnormalities.3 Previously,
adolescents with cervical cytology consistent with
atypical squamous cells of undetermined significance
(ASCUS), in which the HPV test was positive, and
low-grade squamous intraepithelial lesion (LGSIL)
underwent colposcopy. Under new guidelines those
patients with ASCUS or LGSIL may undergo cytology
testing at twelve months, without affecting the severity
of disease as most low grade disease will spontaneously
resolve. No need for invasive testing is necessary in this
population unless it persists beyond two years (3).
Since adolescent compliance with follow-up has
been reported in the literature to be poor, the authors
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were concerned that this change may delay the diagnosis of moderate or severe cervical dysplasia, as well as
the appropriate follow up of adolescents with cervical
cytologic abnormalities. The estimated rate of noncompliance with follow-up appointments ranges from
26-50% over one to two years(4,5). This non-compliance has been associated with younger age, lower
educational level, unmarried status and the lack of
insight of adolescents into the disease process(6,7).
Objectives
The primary objective of this study was to determine
the compliance with follow up in adolescent patients
with cervical dysplasia as well as the risk of progression of disease in this population in order to determine
if new guidelines could affect severity of disease or
delay its diagnosis. Our secondary objective was to
summarize outcomes of patients including incidence
of dysplasia, associated risk factors for severity of disease and evaluate if the type of invasive procedure
performed influenced compliance.
Materials and Methods
Adolescent patients (defined women age 12 to 21), who
had a colposcopy between January 2004 and December
2006, were identified by CPT code from a computerized
database after IRB approval at the Center for Women’s
Medicine from Lehigh Valley Hospital. Patients were
excluded from this review if they had a previously
abnormal pap with or without intervention. Referral
for colposcopy was based on one of the following cytologies: ASCUS with high-risk (HR) HPV, LGSIL, or
high-grade squamous intraepithelial lesion (HGSIL).
A chart review was performed to identify demographic
data, referral cytology, histology, and other associated
risk factors such as smoking history, number of sexual
partners, parity, gravity, race, contraceptive choice, and
use of barrier contraception. Follow-up cytology results
and time since initial biopsy were obtained from
a Health Network Laboratory database.
Data were analyzed using SPSS, version 12.0 (SPSS,
Inc., Chicago, IL). After a power calculation of 85%,
parametric statistical tests (independent t test, analysis
of variance (ANOVA), and Pearson correlation) were
used to analyze data with known normal distribution
and adequate sample size. Nonparametric tests (MannWhitney, Kruskal-Wallace, and chi-square) were used
as appropriate. A P value # .05 was considered statistically significant.
Results
There were 210 patients included in this study. Ages
ranged from 14 to 21, with a mean age of
18.74  1.93. Demographic characteristics are included
in Table 1.

Table 1. Demographic Characteristics of the Study Population
(N 5 210)
Number of Patients (%)
Hispanic
Black
Caucasian
Pregnant at time of diagnosis
Lifetime sexual partners
1
O1
Birth control
Barrier method
HIV negative
positive
History of STI
Tobacco use
Age of diagnosis (y) (mean  SD)
Gravity
Parity

122
16
71
52

(57.8%)
(7.6%)
(33.6%)
(24.6%)

125 (59%)
86 (41%)
107 (51%)
44 (20.9%)
207 (98%)
4 (2%)
64 (30.3%)
76 (36%)
18.74  1.93
1.11  1.03
0.70  0.80

Abbreviations: STI, sexually transmitted infection; HIV, human
immunodeficiency virus.

Initial cytology results and patients requiring colposcopy and surgical intervention for Cervical intraepithelial neoplasia (CIN) 2 or higher are shown in
Table 2. All patients had an endocervical curetting
(ECC) at the time of their colposcopy and surgical
excision.
One hundred thirty-two (62.9%) patients had at least
1 documented follow-up visit, with a mean time to follow-up from diagnosis of 11.44  7.48 months. Mean
time to follow-up for patients with a surgical
intervention was 12.72  8.9 months and 11.02  7.08
months for those without a surgical intervention
(P 5 .371). There was a significant (P ! .001) positive
correlation (r 5 0.310) between time to follow-up and
age, but no difference was seen based on pregnancy status, race, or surgical intervention (Fig. 1).
Table 2. Characteristics of Initial Cytology and Histology
Initial Cytology
ASCUS HRHPV
LGSIL
HGSIL
Colposcopy
Required surgical intervention
LEEP
Cone biopsy
Final histology after surgery (%)
CIN I
CIN II
CIN III
Negative endocervical curetting (%)

n (%)
125
68
9
118
32
28
4

(61.9)
(33.7)
(4.5)
(55.9)
(15.2)
(87.5)
(12.5)

34.4
37.5
28.1
100

Abbreviations: ASCUS HR_HPV, atypical cells of undetermined
significance with high-risk human papilloma virus; CIN, cervical
intraepithelial neoplasia; LGSIL, low-grade squamous intraepithelial lesion; HGSIL, high-grade squamous intraepithelial lesion.
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9.5

Non-pregnant
Surgery
Conservative
Management

Fig. 1. Time to follow-up (there was no statistical significance when comparing any of the groups)

Results at time of follow-up are shown in Table 3.
On multivariate analysis, tobacco use was significantly associated with progression of disease. Patients
who did not use tobacco were significantly more
likely to have improvement in their cytology than
women who used tobacco (odds ratio [OR] 2.17;
95% confidence interval [CI] 1.03-4.55; P 5 .039).
Patients with negative ectocervical margins were approximately 5.25 times more likely to have regression of
disease (OR 5.35; 95% CI 1.39-20.54; P 5 .008). Patients with negative endocervical margins were 3 times
more likely to improve than those with negative ectocervical margins (OR 3.12; 95% CI 0.997-9.74; P 5 .043).
There was no statistically significant regression at time
of follow-up based on age, pregnancy at time of diagnosis, use of contraception, history of sexually transmitted
diseases, or time to follow-up (Table 3).
Patients who did not follow up (37.1%) had no statistical significant differences in age, race, smoking,
or severity of initial cytological abnormality when
compared to the patients who had subsequent visits.
Discussion
An estimated 20 million Americans are currently
infected with the HPV virus yearly, and more than
30 million cases are seen worldwide yearly; 5.5 million
of these new cases are diagnosed in the United States,
with an estimated infection rate in adolescents reaching
74%.8e10 Although most initial infections in adolescents are generally cleared, there remain a number
of these patients who silently harbor the HPV virus in
cervical cells, which become active at some time in
the future, leading to the recognition of dysplasia. Once
infected, HPV induces pathologic changes in cervical
cells due to effects of viral proteins expressed during active HPV infection. These changes include basal cell
proliferation, nuclear enlargement, koilocytosis, and
abnormal mitotic figures.11

Before the release of the new guidelines recommended by the ASCCP in 2006, dysplasia in adolescents and adults were managed similarly. New
evidence about the natural history of HPV infection
demonstrates that it is often transient in young
women, with the majority of cases of CIN I and II
regressing within 2 years.2,12 Because of the high
resolution rates in this population, the traditional
management of colposcopy and ablative treatment in
older women has changed to surveillance and repeat
cytology in adolescents. Treatment or excision is
recommended only when there is persistence of CIN
2 on biopsy for over 2 years.3 Though a small percentage of CIN 3 will regress, these lesions are more
likely to progress to cervical cancer when compared
to CIN 1 and 2. Nonetheless, the incidence of cervical
cancer in girls aged 10-14 years remains 0 per
100 000 per year and 1.7 per 100 000 for those aged
15-19 years.13 Therefore, current recommendations
support managing CIN 3 in the adolescent similar to
that in adult women, with excisional procedures.3
Although these new recommendations are medically
reasonable, the issue of compliance is important to consider. Unfortunately, there are a substantial number of
patients lost to follow-up. Delayed follow-up may
result in delayed relay of results and treatment. Historical data suggest the compliance in adolescents is as low
as 24% at 2 years, even after having an excisional
Table 3. Follow-up Cytology Characteristics (n [%])
Original Cytology Worsen Unchanged Improved
ASCUS HR-HPV 26 (31.7) 12 (14.6) 44
LGSIL
3 (7.7) 12 (30.8) 24
HGSIL
0 (0)
0 (0)
4
All results
29 (23.2) 24 (19.2) 72

Total

(53.7)
82
(61.5)
39
(100.0)
4
(57.6) 125

(100.0)
(100.0)
(100.0)
(100)

Abbreviations: ASCUS HR_HPV, atypical cells of undetermined
significance with high-risk human papilloma virus; LGSIL, lowgrade squamous intraepithelial lesion; HGSIL, high-grade squamous intraepithelial lesion.
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Table 4. Characteristics and Factors Associated with Follow-up Cytology Results

Age (y) (mean  SD)
Race (%)

Lifetime sexual partners (%)
No tobacco use (%)
Pregnant (%)
Gravida
Parity
Contraceptive use (%)

Hispanic
Caucasian
African-American
1
O1

None
Injection
OCP
Patch

Condom use (%)
History STI (%)
Surgical intervention (%)
Ectocervix margins (%)
Endocervix margins (%)
Months to follow-up (mean  SD)

Improved

Unchanged

Worsened

P Value

18.68  1.78
61.6
53.7
40.0
64.7
56.1
64.6
52.5
1.06  0.963
0.57  0.65
61.9
63.0
45.2
50.0
62.5
61.1
55.0
23.1
33.3
12.20  7.51

19.00  2.04
15.1
26.8
20.0
17.6
17.5
16.5
15.0
1.21  0.93
0.83  0.76
17.5
11.1
32.3
0
20.8
25.5
30.0
38.5
33.3
12.43  8.80

18.48  1.77
23.3
19.5
40.0
17.6
26.3
19.0
32.5
1.07  0.92
0.72  0.75
20.6
25.9
22.6
50
16.7
23.4
15.0
38.5
33.3
8.88  6.12

.588
.366

.421
.039
.429
.553
.123
.415

.589
.251
.687
.008
.043
.257

Abbreviation: STI, sexually transmitted infections.

procedure such as a LEEP.5,14 In our study, the noncompliance rate was 40% at 1 year, which is similar
to previous reports.5,14
Noncompliance has been associated with younger
age, lower educational level, unmarried status, lack of
adequate health insurance, better overall health, lowergrade cervical lesions, as well as lack of understanding
of the significance of their abnormality.7 Women in poor
and minority communities have been identified as being
less likely to use screening cytology. In addition, they are
less likely to follow up after an abnormal result. Lower
rates have also been observed among ethnic groups, including Southeast Asian, black, and Hispanic women.
This loss to follow-up may contribute to the substantially
higher rate of invasive cervical carcinoma observed
among poor and minority women.15,16 For all these reasons, delaying further testing for 12 months in patients
with an abnormal cytology may contribute to a delay
in diagnosis and management.
Through our analysis, there appears to be no
difference in compliance with follow-up (Table 4), regardless of severity of disease, surgical intervention,
or any demographic characteristics; those who did not
return for follow-up did not differ significantly than
those who did. Patients returned for follow-up around
a year after their initial colposcopy. Our data also suggest that there is no significant progression of disease
and high regression rates of cytological abnormalities.
There appears to be a correlation with smoking and persistence of disease, which has been previously described in the literature.2 One could assume that
patients who undergo a surgical intervention or a colposcopy for cytological abnormalities would be more
likely to return for follow-up. Our data continue to show

that despite surgical intervention, patients still returned
for reassessment at the same time as those who did not
undergo treatment.
Conclusion
The present study supports the current guidelines to
delay aggressive intervention in adolescents, as they
tend to follow up at 12 months even if surgical intervention is required, and no significant changes in severity
of disease are observed. New ACOG and ASCCP
guidelines to repeat cytology without HPV testing in
12 months rather than colposcopy may be appropriate
for this population, as progression of disease will not
increase and is likely to regress.2,3 Care should be
undertaken to properly educate our patients about
their disease and make them aware that, although their
abnormality does not require further evaluation at the
time of diagnosis, repeat cytology is necessary to identify those patients with persistent disease who may be at
risk for severe dysplasia (CIN 3) and require treatment.
Acknowledgement: The authors would like to thank Sharon
Kimmell, PhD for her assistance with the statistical analysis.
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